Recent Updates
Recently added Catalysts
ABBV Positive Sentiment

AbbVie to Present at the Bank of America Securities Healthcare Conference

Wednesday, May 6, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbbVie will participate in the Bank of America Securities Healthcare Conference on May 13, 2026. The management team will engage in a fireside chat at 1:20 p.m. Central Time, which will be available via a live audio webcast. An archived version will also be accessible later that day.
Price reaction · baseline $206.11 (2026-05-05 close) · hit after-hours · clean, no other ABBV news in the window
day 0 close · peak
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie is actively engaging with investors at a major conference.
  • The company is showcasing its commitment to innovative healthcare solutions.
  • Live audio webcasts enhance accessibility for stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
paricalcitol
Phase 3 · Secondary Hyperparathyroidism

Full Press Release Details

NORTH CHICAGO, Ill.,May 6, 2026/PRNewswire/ -- AbbVie (NYSE:ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 13, 2026. Management will participate in a fireside chat at 1:20 p.m. Central Time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website atinvestors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie onLinkedIn,Facebook,Instagram,XandYouTube.
Media:Gabby DioGuardi(224) 244-0111[email protected] Investors:Liz Shea(847) 935-2211[email protected]

Investors:

Liz Shea(847) 935-2211
[email protected]

Frequently Asked Questions

When is AbbVie's presentation at the conference?

AbbVie's presentation is scheduled for May 13, 2026.

How can I access the presentation?

The presentation will be available via a live audio webcast on AbbVie's Investor Relations website.

What time will AbbVie's management participate?

Management will participate in a fireside chat at 1:20 p.m. Central Time.

Will there be an archived version of the presentation?

Yes, an archived edition will be available later on the same day.

ShareAdd on Google
Tags: ABBV Viatris Investor Conferences Healthcare AbbVie Bank of America Healthcare Conference Investor Relations presentation
Last updated: May 6, 2026

Biotech snapshot

Cash runway
$6569M liquidity · $0M/mo burn
Low dilution risk
Lead asset
paricalcitolPhase 3
Secondary Hyperparathyroidism →

Catalyst track record

+33%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →